Jim Simons Pyxis Oncology, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 148,000 shares of PYXS stock, worth $489,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,000
Previous 364,150
59.36%
Holding current value
$489,880
Previous $655,000
3.82%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PYXS
# of Institutions
76Shares Held
23.5MCall Options Held
88.6KPut Options Held
47K-
Deep Track Capital, LP Greenwich, CT4.18MShares$13.8 Million0.59% of portfolio
-
Laurion Capital Management LP New York, NY3.86MShares$12.8 Million0.14% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.59MShares$8.59 Million0.02% of portfolio
-
Stem Point Capital LP New York, NY1.79MShares$5.94 Million2.02% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.66MShares$5.5 Million0.94% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $116M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...